Cargando…

Impact of semaphorin expression on prognostic characteristics in breast cancer

Breast cancer is one of the major causes of cancer-related deaths among women worldwide. Aberrant regulation of various growth factors, cytokines, and other proteins and their receptors in cancer cells drives the activation of various oncogenic signaling pathways that lead to cancer progression. Sem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Butti, Ramesh, Kumar, Totakura VS, Nimma, Ramakrishna, Kundu, Gopal C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5987790/ https://www.ncbi.nlm.nih.gov/pubmed/29910635 http://dx.doi.org/10.2147/BCTT.S135753

Ejemplares similares

Chloroxylon swietenia (Roxb.) DC induces cell death and apoptosis by down‐regulating the NF‐κB pathway in MCF‐7 breast cancer cells: In vitro and in vivo investigations
por: Kamble, Sonali S., et al.
Publicado: (2022)

Receptor tyrosine kinases (RTKs) in breast cancer: signaling, therapeutic implications and challenges
por: Butti, Ramesh, et al.
Publicado: (2018)

Tumor-associated macrophage derived IL-6 enriches cancer stem cell population and promotes breast tumor progression via Stat-3 pathway
por: Radharani, N. N. V., et al.
Publicado: (2022)

Semaphorins and Their Roles in Breast Cancer: Implications for Therapy Resistance
por: Aiyappa-Maudsley, Radhika, et al.
Publicado: (2023)

Semaphorin 3A Suppresses Tumor Growth and Metastasis in Mice Melanoma Model
por: Chakraborty, Goutam, et al.
Publicado: (2012)

The semaphorins
por: Yazdani, Umar, et al.
Publicado: (2006)

Semaphorin Signaling in Cancer-Associated Inflammation
por: Franzolin, Giulia, et al.
Publicado: (2019)

The molecular dialogue between the tumor cells and fibroblasts
por: Butti, Ramesh, et al.
Publicado: (2023)

Polyherbal formulation Anoac-H suppresses the expression of RANTES and VEGF for the management of bleeding hemorrhoids and fistula
por: Porwal, Ashwin, et al.
Publicado: (2021)

Expression of VEGF and Semaphorin Genes Define Subgroups of Triple Negative Breast Cancer
por: Bender, R. Joseph, et al.
Publicado: (2013)

The Role of Semaphorins in Metabolic Disorders
por: Lu, Qiongyu, et al.
Publicado: (2020)

Tumor suppressor SMAR1 regulates PKM alternative splicing by HDAC6-mediated deacetylation of PTBP1
por: Choksi, Arpankumar, et al.
Publicado: (2021)

Semaphorins as emerging clinical biomarkers and therapeutic targets in cancer
por: Mastrantonio, Roberta, et al.
Publicado: (2021)

Semaphorin 4D Promotes Skeletal Metastasis in Breast Cancer
por: Yang, Ying-Hua, et al.
Publicado: (2016)

The Role of Semaphorins and Their Receptors in Gliomas
por: Law, Janice Wai Sze, et al.
Publicado: (2012)

Neuroimmune semaphorins as costimulatory molecules and beyond
por: Chapoval, Svetlana P.
Publicado: (2018)

Class 3 semaphorins in cardiovascular development
por: Valdembri, Donatella, et al.
Publicado: (2016)

Role of Semaphorins in Immunopathologies and Rheumatic Diseases
por: Garcia, Samuel
Publicado: (2019)

Multifaceted Functional Role of Semaphorins in Glioblastoma
por: Angelucci, Cristiana, et al.
Publicado: (2019)

457 Semaphorin7a expression in breast cancer promotes susceptibility to immune checkpoint blockade
por: Elder, Alan, et al.
Publicado: (2022)

Semaphorin 7a is a biomarker for recurrence in postpartum breast cancer
por: Borges, Virginia F., et al.
Publicado: (2020)

Serum semaphorin4C as an auxiliary diagnostic biomarker for breast cancer
por: Wang, Ya, et al.
Publicado: (2021)

Semaphorin, neuropilin and VEGF expression in glial tumours: SEMA3G, a prognostic marker?
por: Karayan-Tapon, L, et al.
Publicado: (2008)

Pathophysiological functions of semaphorins in the sympathetic nervous system
por: Mizuno, Yumiko, et al.
Publicado: (2023)

Herbal medicine AnoSpray suppresses proinflammatory cytokines COX-2 and RANTES in the management of hemorrhoids, acute anal fissures and perineal wounds
por: Porwal, Ashwin, et al.
Publicado: (2022)

Semaphorin 3C as a Therapeutic Target in Prostate and Other Cancers
por: Hui, Daniel H.F., et al.
Publicado: (2019)

Semaphorin 3C and Its Receptors in Cancer and Cancer Stem-Like Cells
por: Hao, Jing, et al.
Publicado: (2018)

Semaphorins—not just for axons
por: LeBrasseur, Nicole
Publicado: (2002)

Enhanced expression of semaphorin 3E is involved in the gastric cancer development
por: Maejima, Ryuhei, et al.
Publicado: (2016)

Successful Inhibition of Tumor Development by Specific Class-3 Semaphorins Is Associated with Expression of Appropriate Semaphorin Receptors by Tumor Cells
por: Kigel, Boaz, et al.
Publicado: (2008)

The role of semaphorin 4D in tumor development and angiogenesis in human breast cancer
por: Jiang, Hongchao, et al.
Publicado: (2016)

Hormonal Regulation of Semaphorin 7a Promotes Therapeutic Resistance in Breast Cancer
por: Crump, Lyndsey, et al.
Publicado: (2021)

Role of Semaphorin Signaling During Cardiovascular Development
por: Sun, Qianchuang, et al.
Publicado: (2018)

Expression of Semaphorin 3A and Neuropilin 1 in Asthma
por: Shim, Eun-Jin, et al.
Publicado: (2013)

Semaphorins and their receptors: Novel features of neural guidance molecules
por: KUMANOGOH, Atsushi, et al.
Publicado: (2010)

Emerging roles for semaphorins and VEGFs in synaptogenesis and synaptic plasticity
por: Tillo, Miguel, et al.
Publicado: (2012)

Emerging roles of Semaphorins in the regulation of epithelial and endothelial junctions
por: Treps, Lucas, et al.
Publicado: (2013)

SEMAPHORINS and their receptors: focus on the crosstalk between melanoma and hypoxia
por: Valentini, Elisabetta, et al.
Publicado: (2021)

Role of Semaphorin 3A in Kidney Development and Diseases
por: Sang, Yizhen, et al.
Publicado: (2023)

Semaphorins as Potential Immune Therapeutic Targets for Cancer
por: Jiang, Jun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ouhv4h037il3i12tarvgu55vk5